澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - abiraterone acetate, quantity: 250 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; lactose monohydrate; povidone; sodium lauryl sulfate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - te-abiraterone is indicated in combination with prednisolone for the treatment of:,? newly diagnosed high-risk metastatic hormone sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (adt), or,? patients with metastatic advanced prostate cancer (castration resistant prostate cancer, mcrpc) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (adt) or,? patients with mcrpc who have received prior chemotherapy containing a taxane

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

wai shun pty ltd - gardenia jasminoides, quantity: 50 mg (equivalent: gardenia jasminoides, qty 500 mg); cyperus rotundus, quantity: 50 mg (equivalent: cyperus rotundus, qty 1 g); curcuma zedoaria, quantity: 50 mg (equivalent: curcuma zedoaria, qty 715 mg); bupleurum falcatum, quantity: 40 mg (equivalent: bupleurum falcatum, qty 344 mg); abrus cantoniensis, quantity: 75 mg (equivalent: abrus cantoniensis, qty 1.5 g); hypericum japonicum, quantity: 60 mg (equivalent: hypericum japonicum, qty 1.284 g); inula britannica, quantity: 50 mg (equivalent: inula britannica, qty 625 mg); desmodium styracifolium, quantity: 75 mg (equivalent: desmodium styracifolium, qty 1.605 g) - capsule, hard - excipient ingredients: purified talc; gelatin - traditionally used in chinese medicine to maintain/support natural liver cleansing/detoxification processes ; traditionally used in chinese medicine to helps enhance/promote healthy gallbladder function ; traditionally used in chinese medicine to maintain/support urinary tract health

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

wai shun pty ltd - astragalus membranaceus,coptis chinensis,lonicera japonica -

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

wai shun pty ltd - polyporus umbellatus, quantity: 10 mg; wolfiporia cocos, quantity: 6 mg; rosa laevigata, quantity: 21 mg; polygonum aviculare, quantity: 10 mg; glycyrrhiza uralensis, quantity: 7 mg; biota orientalis, quantity: 15 mg; epimedium brevicornu, quantity: 9 mg; dioscorea oppositifolia, quantity: 18 mg; cyathula officinalis, quantity: 37 mg; loranthus parasiticus, quantity: 11 mg; cornus officinalis, quantity: 67 mg; plantago asiatica, quantity: 22 mg; alisma orientale, quantity: 22 mg; euryale ferox, quantity: 18 mg; angelica polymorpha, quantity: 37 mg; paeonia lactiflora, quantity: 29 mg; lycium barbarum, quantity: 89 mg; dipsacus asper, quantity: 16 mg; cuscuta hygrophilae, quantity: 21 mg; oyster shell, quantity: 6 mg; scutellaria baicalensis, quantity: 16 mg - capsule, hard - excipient ingredients: gelatin; purified talc - decrease/reduce/relieve mild joint aches and pains ; maintain/support healthy sleeping patterns ; help maintain/support healthy prostate function

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

nu skin enterprises australia inc - camellia sinensis, quantity: 250 mg (equivalent: camellia sinensis, qty 5 g; equivalent: caffeine, qty 1.25 mg; equivalent: epigallocatechin-3-0-gallate, qty 95 mg) - capsule, hard - excipient ingredients: purified water; gelatin; silicon dioxide; stearic acid; microcrystalline cellulose - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support general health and wellbeing

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; purified talc; ammonio methacrylate copolymer; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - sugammadex sodium, quantity: 544 mg (equivalent: sugammadex, qty 500 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - sugammadex sodium, quantity: 217.6 mg (equivalent: sugammadex, qty 200 mg) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.